There were 12 studies reporting serous carcinoma, for instance, of which 7 used IHC as an analyzing method, 6 used RT-PCR on RNA, 1 ISH, 2 used immunoblots, and 2 were through the use of [125I]-FSH-binding radioreceptor assay. Here, BRD2 is linked to serous adenocarcinoma.